Table 1.
Definition | Prevalence | 95% Confidence Interval |
---|---|---|
| ||
de Ferranti et al Circulation, 2004; 110, 2494–97 |
17.5% | 14.5 %–21.1% |
Ford et al Diabetes Care, 2005; 28, 871–81 |
4.9% | 3.7%–6.5% |
Cook et al. Arch Pediatr Adolesc Med, 2003; 157, 821–7 |
4.9% | 3.7%–6.5% |
Weiss et ala N Engl J Med, 2004; 350, 2362–74 |
0.5% | 0.3%–1.0% |
Cruz et ala J Clin Endocrinol Metab, 2004; 89, 108–13 |
1.6% | 1.1%–2.2% |
Alberti, G.; Zimmet et al “The IDF consensus definition of metabolic syndrome in children and adolescents,” available at http://www.idf.org/ |
2.0% | 1.4%–2.7% |
IDF: International diabetes federation.
Partial criteria, based on 4 out of 5 indicators, with missing impaired d glucose tolerance. Included only for comparison to IDF criterion.